Access to Patient Data

Xcelerate^™ Health Outcomes (XHO) is able to identify leading KOLs by making use of NHSIL's existing relationships with the Trusts. XHO draws upon these relationships to gain access to Trust anonymised patient data*. Trusts are generally sensitive to industry and consultancies accessing data, therefore, XHO can bridge gap between industry and Trusts. XHO are already undertaking projects with industry to collect patient data. Agreements and processes are already in place to conduct this type of study.

XHO are experienced in the internal approval (R&D) systems of the Trusts. Based on past studies XHO are able to identify Trusts who are a key player in specialised therapy research.

Types of data which we can provide access to:

• Real-world usage
• Socioeconomic and socio-demographic data
• Clinical data
• Length of stay
• Length of treatment
• Reasons patients switch to another procedure
• Costing data and resource use
• Quality of life data

How patient data studies are run:

• We identify sources within the NHS that have real-world retrospective and prospective outcomes data across all therapeutic areas
• We work with KOL in setting up project
• We set up all agreements & documentation prior to commencement of the study
  • Financial & data confidentiality
  • MREC approval & opinion letter
  • Protocol
  • Indemnity document
  • PI CV
  • Case Report Form (CRF)*
• We work with Trust R&D to approve study
  • Checklist
  • R&D form
  • Site Specific Information (SSI) form
  • IRAS
• We provide a dedicated project management team to manage studies, timelines, key milestones and site training
• We will design CRF for data capture
• Cleansing and aggregation of outcomes data to ensure anonymity
• We provide analysis and data population for models

For more information contact Andy Ingram - Head of Xcelerate^™ Health Outcomes.

*XHO has agreements in place with NHS Trusts to ensure all patient identifiers are removed before XHO receive the data.